New York - Researchers have identified a molecular biomarker that was shown in a study to predict survival in melanoma patients, independently of tumor thickness and other known prognostic indicators.
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
Managing Food Allergies with Dupilumab in Pediatric Dermatology